Ella H. Sklan

3.4k total citations
61 papers, 2.4k citations indexed

About

Ella H. Sklan is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Ella H. Sklan has authored 61 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Epidemiology and 14 papers in Hepatology. Recurrent topics in Ella H. Sklan's work include Hepatitis C virus research (13 papers), Mosquito-borne diseases and control (12 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). Ella H. Sklan is often cited by papers focused on Hepatitis C virus research (13 papers), Mosquito-borne diseases and control (12 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). Ella H. Sklan collaborates with scholars based in Israel, United States and Germany. Ella H. Sklan's co-authors include Hermona Soreq, Jeffrey S. Glenn, Shirit Einav, Menashe Elazar, Chava Perry, Erez Podoly, Klara R. Birikh, Jae U. Jung, Amir Shlomai and Shai Shoham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ella H. Sklan

58 papers receiving 2.3k citations

Peers

Ella H. Sklan

PHARM

EPIDE

HEPAT

Helmut Jacobsen Switzerland

John Watson United Kingdom

Massimo Santoro Italy

Peter Nickel Germany

Wen‐Zhe Ho United States

Yves Rouillé France

Francine Gervais Canada

Yan Wu China

Krister Melén Finland

Helmut Jacobsen Switzerland

Ella H. Sklan

1.5k ×1.5

517 ×1.2

PHARM

1000 ×2.3

EPIDE

918 ×2.2

HEPAT

699 ×2.0

Citations per year, relative to Ella H. Sklan Ella H. Sklan (= 1×) peers Helmut Jacobsen

Countries citing papers authored by Ella H. Sklan

Since Specialization

Citations

This map shows the geographic impact of Ella H. Sklan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella H. Sklan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella H. Sklan more than expected).

Fields of papers citing papers by Ella H. Sklan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ella H. Sklan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella H. Sklan. The network helps show where Ella H. Sklan may publish in the future.

Co-authorship network of co-authors of Ella H. Sklan

This figure shows the co-authorship network connecting the top 25 collaborators of Ella H. Sklan. A scholar is included among the top collaborators of Ella H. Sklan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella H. Sklan. Ella H. Sklan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campos, Túlio de Lima, Victoria Indenbaum, Le Thi Hoi, et al.. (2025). Circulating lncRNAs as biomarkers for severe dengue using a machine learning approach. Journal of Infection. 90(4). 106471–106471.

Sklan, Ella H., et al.. (2025). Association of anti-interferon antibodies with severe clinical outcomes in West Nile virus: Results of a recent outbreak. International Journal of Infectious Diseases. 163. 108282–108282.

Yoo, Ji‐Seung, et al.. (2025). Dysregulated immune cell responses in severe dengue pathogenesis. Frontiers in Immunology. 16. 1600999–1600999.

Press, Konstantin, et al.. (2024). SVX-Enhanced Gradual Release System: A Novel Biotechnological Approach for Alpha-Hydroxy Acids and Hyaluronic Acid in Skincare. Journal of Cosmetics Dermatological Sciences and Applications. 14(4). 357–371. 1 indexed citations

Press, Konstantin, et al.. (2024). SVX Spider Silk-Inspired Biopolymer and Enhanced Cosmetics Efficacy. Cosmetics. 11(5). 166–166. 2 indexed citations

Ngo, Truong-Giang, Cấn Văn Mão, Lan Hieu Nguyen, et al.. (2023). Complement receptor type 1 and 2 (CR1 and CR2) gene polymorphisms and plasma protein levels are associated with the Dengue disease severity. Scientific Reports. 13(1). 17377–17377. 5 indexed citations

Lustig, Yaniv, et al.. (2023). The Role of NS1 Protein in the Diagnosis of Flavivirus Infections. Viruses. 15(2). 572–572. 26 indexed citations

Alcântara, Luíz Carlos Júnior, Robin Andersson, Young Ki Choi, et al.. (2022). Methods for fighting emerging pathogens. Nature Methods. 19(4). 395–397. 1 indexed citations

Yaffe, Yakey, Eitan Erez Zahavi, Anna Dukhovny, et al.. (2021). COPII collar defines the boundary between ER and ER exit site and does not coat cargo containers. The Journal of Cell Biology. 220(6). 64 indexed citations

10.

Avram, Oren, Haim Ashkenazy, ‪Yasmin Maor‬‏, et al.. (2021). Domain-Scan: Combinatorial Sero-Diagnosis of Infectious Diseases Using Machine Learning. Frontiers in Immunology. 11. 619896–619896. 8 indexed citations

11.

Shlomai, Amir, et al.. (2020). Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients. Critical Care. 24(1). 539–539. 28 indexed citations

12.

Shlomai, Amir, Ari Leshno, Ella H. Sklan, & Moshe Leshno. (2020). Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis. Value in Health. 24(5). 607–614. 16 indexed citations

13.

Hung, Yu-Fu, Melanie Schwarten, Silke Hoffmann, et al.. (2015). Dengue virus NS4A cytoplasmic domain binding to liposomes is sensitive to membrane curvature. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(5). 1119–1126. 22 indexed citations

14.

Lee, Choongho, Han Ma, Julie Q. Hang, et al.. (2011). The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein. Virology. 414(1). 10–18. 62 indexed citations

15.

Mor, Inbal, Ella H. Sklan, Erez Podoly, et al.. (2008). Acetylcholinesterase‐R increases germ cell apoptosis but enhances sperm motility. Journal of Cellular and Molecular Medicine. 12(2). 479–495. 31 indexed citations

16.

Sklan, Ella H. & Jeffrey S. Glenn. (2007). The Power of Silence: Application of Small Interfering RNAs to Gastrointestinal Diseases. Gastroenterology. 132(7). 2291–2295. 4 indexed citations

17.

Grisaru, Dan, Marjorie Pick, Chava Perry, et al.. (2006). Hydrolytic and Nonenzymatic Functions of Acetylcholinesterase Comodulate Hemopoietic Stress Responses. The Journal of Immunology. 176(1). 27–35. 55 indexed citations

18.

Sklan, Ella H., Erez Podoly, & Hermona Soreq. (2006). RACK1 has the nerve to act: Structure meets function in the nervous system. Progress in Neurobiology. 78(2). 117–134. 109 indexed citations

19.

Perry, Chava, Ella H. Sklan, Klara R. Birikh, et al.. (2002). Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene. 21(55). 8428–8441. 77 indexed citations

20.

Sklan, Ella H., Aviv Gazit, & Esther Priel. (2000). Inhibition of Murine AIDS (MAIDS) Development in C57BL/6J Mice by Tyrphostin AG-1387. Virology. 278(1). 95–102. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact